More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...